Q -- Beryllium Lymphocyte Proliferation Tests

NOTICE OF INTENT TO SOLE SOURCE: The National Institute for Occupational Safety and Health (NIOSH), in Morgantown, WV is currently involved in a project to examine whether individuals who have been exposed to beryllium, a light weight metal which causes chronic granulomatous lung disease, have become sensitized to it. Our requirement is to perform 300 EACH of a laboratory screening blood test, Beryllium Lymphocyte Proliferation Test (BLPT). The NIOSH Field Studies Branch currently has a contract in place for Beryllium-specific Lymphocyte Proliferation Test (BLPT) with Speciality Laboratories, Santa Monica, CA. Specialty Laboratories was the successful offeror under a competitive procurement conducted by NIOSH in March 2000 and was selected based on both cost and technical issues. For research purposes, we now require that any additional BLPT tests for this project be analyzed from the same laboratory to ensure the comparability of research data. This notice is issued for informational purposes only. Any interested party may submit a capabilities statement to be received in the contracting office no later than seven (7) days from the date of this announcement. Submit information to Brenda Goodwin, MS-1019, Reference: 03RDS2-036, DHHS/PHS/CDC/NIOSH/ALOSH, 1095 Willowdale Road, Morgantown, WV 26505. Award will be made under the authority of 41 U.S.C. 253(c)(1). This is a simplified acquisition with an estimated value of less than $100,000. The intent of this synopsis is to determine if any sources exist, therefore, no solicitation will be issued. If no responses are received within 7 days, award will be made to Specialty Laboratories without further notices being issued. All responses received shall be considered by the Government.